Myeloma Paper of the Day, June 14th, suggested by Robert Orlowski

Robert Orlowski shared on X:

“Myeloma Paper of the Day: Clonal hematopoiesis may be frequent (24% out of this 65 patient cohort) in patients receiving CD19- and BCMA-targeted CAR T, and may be associated with more severe cytokine release syndrome.”

Source: Robert Orlowski/X

Clonal Hematopoiesis is Associated with Severe Cytokine Release Syndrome in Patients Treated with Chimeric Antigen Receptor T-cell (CART) Therapy

Authors: Scott R. Goldsmith, Geoffrey Shouse, F. Lennie Wong, Alysia Bosworth, Aleksi Iukuridze, Sitong Chen, June-Wha Rhee, Matthew Mei, Myo Htut, Murali Janakiram, Stephen J. Forman, Raju Pillai, L Elizabeth Budde, and  Saro H. Armenian.

Other posts featuring Robert Orlowski on OncoDaily.

Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.

Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.